Cargando…

Magnetic resonance imaging findings for discriminating clear cell carcinoma and endometrioid carcinoma of the ovary

BACKGROUND: Common cancerous histological types associated with endometriosis are clear cell carcinoma (CCC) and endometrioid carcinoma (EC). CCC is regarded as an aggressive, chemoresistant histological subtype. Magnetic resonance imaging (MRI) offers some potential advantages to diagnose ovarian t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Morioka, Sachiko, Kawaguchi, Ryuji, Yamada, Yuki, Iwai, Kana, Yoshimoto, Chiharu, Kobayashi, Hiroshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6388492/ https://www.ncbi.nlm.nih.gov/pubmed/30803452 http://dx.doi.org/10.1186/s13048-019-0497-1

Ejemplares similares

Two Cases of Dedifferentiated Endometrioid Carcinoma: Case Presentation and Brief Review of the Literature
por: Morioka, Sachiko, et al.
Publicado: (2018)

Clinicopathological correlations of endometrioid and clear cell carcinomas in the uterus and ovary
por: Mori, Hidemi, et al.
Publicado: (2023)

Toward an understanding of the pathophysiology of clear cell carcinoma of the ovary (Review)
por: UEKURI, CHIHARU, et al.
Publicado: (2013)

Sertoliform endometrioid carcinoma of the right ovary
por: Alali, Mohammad, et al.
Publicado: (2023)

The HNF-1β―USP28―Claspin pathway upregulates DNA damage-induced Chk1 activation in ovarian clear cell carcinoma
por: Ito, Fuminori, et al.
Publicado: (2018)

Endometriosis in clear cell and endometrioid carcinoma ovary: its impact on clinicopathological characteristics and survival outcomes
por: Kundur, Mythili, et al.
Publicado: (2023)

Role of serum microRNAs as biomarkers for endometriosis, endometrioid carcinoma of ovary & endometrioid endometrial cancer
por: Kumari, Priti, et al.
Publicado: (2022)

Sertoliform Endometrioid Carcinoma of Ovary Presenting as Abdominal Wall Abscess
por: Subbaiah, Murali, et al.
Publicado: (2018)

Concomitant endometrioid carcinoma of the ovary and endometrial carcinoma of the uterus associated with adenocarcinoma in situ of the cervix.
por: Parker, M., et al.
Publicado: (1989)

The Association between Primary Endometrioid Carcinoma of the Ovary and Synchronous Malignancy of the Endometrium
por: van Niekerk, Catharina C., et al.
Publicado: (2010)

Ovarian endometrioid carcinoma and clear cell carcinoma: A 21-year retrospective study
por: Zhou, Ling, et al.
Publicado: (2021)

The ARID1A, p53 and ß-Catenin statuses are strong prognosticators in clear cell and endometrioid carcinoma of the ovary and the endometrium
por: Heckl, Marlene, et al.
Publicado: (2018)

Endometrioid Carcinomas of the Ovaries and Endometrium Involving Endocervical Polyps: Comprehensive Clinicopathological Analyses
por: Sohn, Jihee, et al.
Publicado: (2022)

Frequency and clinical features of deficient mismatch repair in ovarian clear cell and endometrioid carcinoma
por: Tanaka, Tamaki, et al.
Publicado: (2022)

Subtype I (intrinsic) adenomyosis is an independent risk factor for dienogest-related serious unpredictable bleeding in patients with symptomatic adenomyosis
por: Matsubara, Sho, et al.
Publicado: (2019)

Validation of tissue factor pathway inhibitor 2 as a specific biomarker for preoperative prediction of clear cell carcinoma of the ovary
por: Miyagi, Etsuko, et al.
Publicado: (2021)

Analysis of Risk Factors for Lymphatic Metastasis in Endometrial Carcinoma and Utility of Three-Dimensional Magnetic Resonance Imaging in Gynecology
por: Tanase, Yasuhito, et al.
Publicado: (2018)

Sertoliform Endometrioid Tumor of Ovary Presenting as Torsion
por: Pai, Prathiksha, et al.
Publicado: (2016)

Clear cell carcinoma of the ovary: multi-slice computed tomography findings
por: Li, Xubin, et al.
Publicado: (2015)

Clear cell carcinoma of the ovary: Is there a role of histology-specific treatment?
por: Takano, Masashi, et al.
Publicado: (2012)

Clinical impact of genetic alterations of CTNNB1 in patients with grade 3 endometrial endometrioid carcinoma
por: Kobayashi Kato, Mayumi, et al.
Publicado: (2022)

Pilomatrix-like High-Grade Endometrioid Carcinoma of the Ovary: Case Report, Literature Review, and Differential Diagnosis
por: Santoro, Angela, et al.
Publicado: (2022)

CCNE1 Is a Putative Therapeutic Target for ARID1A-Mutated Ovarian Clear Cell Carcinoma
por: Kawahara, Naoki, et al.
Publicado: (2021)

A rare case of synchronous right ovarian clear cell carcinoma and an incidental left ovarian endometrioid carcinoma with immunohistochemical study
por: Khandeparkar, Siddhi G. S., et al.
Publicado: (2014)

Prognostic factors of synchronous endometrial and ovarian endometrioid carcinoma
por: Yoneoka, Yutaka, et al.
Publicado: (2018)

VEGF Immunoexpression in Endometrioid Endometrial Carcinomas
por: DROCAŞ, ILEANA, et al.
Publicado: (2022)

Snail Immunoexpression in Endometrioid Endometrial Carcinomas
por: FLORESCU, MIRELA MARINELA, et al.
Publicado: (2022)

Search for conditions to avoid parametrectomy during radical hysterectomy for cervical cancer
por: Ito, Fuminori, et al.
Publicado: (2019)

Genomic mutation features identify distinct BRCA-associated mutation characteristics in endometrioid carcinoma and endometrioid ovarian carcinoma
por: Cao, Canhui, et al.
Publicado: (2021)

Clear-Cell Carcinoma of the Ovary with Bilateral Breast Metastases
por: Galili, Yehuda, et al.
Publicado: (2019)

Targeting Mitochondrial Metabolism in Clear Cell Carcinoma of the Ovaries
por: Zhang, Xiaonan, et al.
Publicado: (2021)

The Endometriotic Neoplasm Algorithm for Risk Assessment (e-NARA) Index Sheds Light on the Discrimination of Endometriosis-Associated Ovarian Cancer from Ovarian Endometrioma
por: Kawahara, Naoki, et al.
Publicado: (2022)

Validation of Novel Prognostic Biomarkers for Early-Stage Clear-Cell, Endometrioid and Mucinous Ovarian Carcinomas Using Immunohistochemistry
por: Engqvist, Hanna, et al.
Publicado: (2020)

Establishment and characterization of a cell line (NOMH-1) originating from a human endometrioid adenocarcinoma of the ovary
por: Yamada, Takashi, et al.
Publicado: (2013)

Clinicopathological Prognostic Parameters of Endometrioid Endometrial Carcinomas
por: DROCAŞ, ILEANA, et al.
Publicado: (2022)

EZH2 inhibition in ARID1A mutated clear cell and endometrioid ovarian and endometrioid endometrial cancers
por: Alldredge, Jill K., et al.
Publicado: (2017)

Ruptured clear cell carcinoma of the ovary presenting as acute abdomen
por: Zhou, Zhen Ni, et al.
Publicado: (2016)

Establishment and characterization of a cell line (HCH-1) originating from a human clear cell carcinoma of the ovary
por: Yamada, Takashi, et al.
Publicado: (2016)

Uterine papillary serous and clear cell carcinomas predict for poorer survival compared to grade 3 endometrioid corpus cancers
por: Hamilton, C A, et al.
Publicado: (2006)

Mutational Analysis of β‐Catenin Gene in Japanese Ovarian Carcinomas: Frequent Mutations in Endometrioid Carcinomas
por: Sagae, Satoru, et al.
Publicado: (1999)

Cannot write session to /tmp/vufind_sessions/sess_077qj57fj4ttp877ig3mim75dd